Most Recent Additions Jefferson Digital Commons*
The history of the present illness as treatment: who's listening, and why does it matter?
Herbert M. Adler, MD, PhD
Management of intracranial bleeding associated with dabigatran use in a neuroscience hospital
Alejandro Perez, MD; Lynda Thomson; and Geno J. Merli, MD
Current and Future Therapies for Pulmonary Arterial Hypertension
Terrence Trow, MD, FACP, FCCP
The Impact of Community Use of Novel Oral Anticoagulants on an Academic Medical Center
Luis Eraso, MD; Taki Galanis, MD; Kristina Kipp, Pharm.D.; Walter K. Kraft, MD; Michael Palladino, Pharm.D., CACP; Alejandro Perez, MD; Kimberle Ferebee-Spruill, CRNP; Geno Merli, MD; Brian G. Swift, Pharm.D., MBA; Lynda Thomson; and Brittany Vining
Predictive value of alpha-fetoprotein in the long-term risk of developing hepatocellular carcinoma in patients with hepatitis B virus infection--results from a clinic-based longitudinal cohort.
Hie-Won Hann, Xiaoying Fu, Ronald E. Myers, Richard Hann, Shaogui Wan, Su Hee Kim, Natalie Au, Jinliang Xing, and Hushan Yang
Early adoption of transoral robotic surgical program: preliminary outcomes.
David Cognetti, Adam Luginbuhl, Anthony L. Nguyen, and Joseph Curry
Repair of Nasal Septal Perforation with Porcine Small Intestinal Submucosa Xenograft
Jewel Greywoode, MD; James Hamilton, MD; Prashant S. Malhotra, MD; Abdel Saad, MD; and Edmund A. Pribitkin, MD
MicroRNAs as targets and targeted therapies in cancer
Frank Slack, PhD
Developmental dysplasia of the hip: Linkage mapping and whole exome sequencing identify a shared variant in CX3CR1 in all affected members of a large multi-generation family.
George J Feldman, Javad Parvizi, Mark Levenstien, Kathryn Scott, Jill A Erickson, Paolo Fortina, Marcella Devoto, and Christopher L Peters
*Updated as of 06/18/13.